Skip to main content

Advertisement

Log in

Prevalence and clinical characteristics of prediabetes and diabetes mellitus in young patients with ST-segment elevation myocardial infarction

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

Only few data on the prevalence of DM in young patients with ST-elevation myocardial infarction (STEMI) exist. Aim of the present study was to analyse this prevalence, its association to other cardiovascular risk factors and its impact on severity of CAD. In a substudy, consecutive HbA1c measurements in each patient were evaluated.

Methods

All patients ≤ 45 years old, admitted with STEMI to an overregional German Heart Centre and treated with primary coronary intervention between 2006 and 2019, entered analysis. Since 2015 HbA1c measurements were performed to detect unknown dysglycaemia.

Results

Out of 776 young patients of the total cohort, 88 patients (11.4%) had a DM, while 688 (88.6%) did not. Diabetics were more likely to be obese (BMI ≥ 30 kg/m2, OR 2.4, 95%CI 1.4–4.0, p < 0.01) and very obese (BMI ≥ 40 kg/m2, OR 5.1, 95%CI 2.1–12.2, p < 0.01). In diabetics, a higher likelihood of subacute STEMI (OR 2.2, 95% CI 1.1–4.5, p < 0.05) and more advanced CAD (OR 1.6, 95% CI 1.0–2.6, p < 0.05) compared to non-diabetics was observed. 208 patients were included in the substudy with HbA1c measurements. Out of those, 26 patients (12%) had known DM, while 17 patients (8%) had newly diagnosed DM and 49 patients (24%) preDM. The combined prevalence of any type of dysglycaemia was 44%.

Conclusion

DM in young patients with STEMI was associated with (severe) obesity, a higher likelihood of subacute STEMI and more advanced CAD compared to non-diabetics. Measurement of HbA1c in every consecutive STEMI-patient increased the rate of detected dysglycaemias more than three times higher than in general population.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. O’Donnell CJ, Elosua R (2008) Cardiovascular risk factors. Insights from Framingham Heart Study. Rev Esp Cardiol 61:299–310

    Article  Google Scholar 

  2. Jacobs E, Hoyer A, Brinks R, Kuss O, Rathmann W (2017) Burden of mortality attributable to diagnosed diabetes: a nationwide analysis based on claims data from 65 million people in Germany. Diabetes Care 40:1703–1709

    Article  Google Scholar 

  3. Shah N, Kelly AM, Cox N, Wong C, Soon K (2016) Myocardial infarction in the “young”: risk factors, presentation, management and prognosis. Heart Lung Circ 25:955–960

    Article  Google Scholar 

  4. World Health Organisation (2016) Global burden on diabetes. In: Library cataloguing-in-publication date, pp 1–88

  5. Tönnies T, Röckl S, Hoyer A, Heidemann C, Baumert J, Du Y, Scheidt-Nave C, Brinks R (2019) Projected number of people with diagnosed Type 2 diabetes in Germany in 2040. Diabet Med 36:1217–1225

    Article  Google Scholar 

  6. Jacobs E, Rathmann W, Tönnies T, Arendt D, Marchowez M, Veith L, Kuss O, Brinks R, Hoyer A (2029) Age at diagnosis of Type 2 diabetes in Germany: a nationwide analysis based on claims data from 69 million people. Diabet Med 37:1723–1727

    Google Scholar 

  7. Luk A, Ke C, Lau E, Wu H, Goggins W, Ma R, Chow E, Kong A, So WJ, Chan J (2020) Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: a retrospective cohort study. PLoS Med 17:e1003052

    Article  Google Scholar 

  8. Vistisen D, Witte D, Brunner E, Kivimäki M, Tabák A, Jørgensen M, Færch M (2018) Risk of cardiovascular disease and death in individuals with prediabetes defined by different criteria: the Whitehall II study. Diabetes Care 41:899–906

    Article  CAS  Google Scholar 

  9. Ibanez B, James S, Agewall S et al (2018) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force on the management acute myocardial infarction in patients presenting with ST-segment elevation of the ESC. Eur Heart J 39:119–177

    Article  Google Scholar 

  10. Steg G, James S, Atar D et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569–2619

    Article  CAS  Google Scholar 

  11. Zeymer U, Kastrati A, Rassaf T, Scholz K-H, Thiele H (2012) ESC Pocket Guidelines Therapie des akuten Herzinfarktes bei Patienten mit persistierender ST-Streckenhebung. Update 2012 Düsseldorf: Deutsche Gesellschaft für Kardiologie

  12. American Diabetes Association (2020) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. Diabetes Care 43:S14–S31

    Article  Google Scholar 

  13. IDF Diabetes Atlas 2019 (2019) International Diabetes Federation, 9th edn. ISBN: 978-2-930229-87-4

  14. Pulgaron E, Delamater A (2014) Obesity and type 2 diabetes in children: epidemiology and treatment. Curr Diab Rep 14:508

    Article  Google Scholar 

  15. Schmucker J, Seide S, Wienbergen H, Fiehn E, Stehmeier J, Günther K, Ahrens W, Hambrecht R, Pohlabeln H, Fach A (2017) Socially disadvantaged city districts show a higher incidence of acute ST-elevation myocardial infarctions with elevated cardiovascular risk factors and worse prognosis. BMC Cardiovasc Disord 17:254

    Article  CAS  Google Scholar 

  16. Malone J, Hansen B (2019) Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? Pediatr Diabetes 20:5–9

    Article  Google Scholar 

  17. Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA, Jacobsen SJ, Frye RL, Roger VL (2002) Coronary atherosclerosis in diabetes mellitus—a population-based autopsy study. J Am Coll Cardiol 40:946–953

    Article  Google Scholar 

  18. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234

    Article  CAS  Google Scholar 

  19. Mehta RH, Milford-Beland S, Peterson ED, Bhatt DL, Farkouh ME, Brogan GX, Gibler WB, Ohman M, Roe MT (2007) Characterizing young patients with diabetes and non-ST-segment elevation acute coronary syndromes. Diabetes Care 30:731–733

    Article  Google Scholar 

  20. McNair P, Bilchick K, Keeley E (2019) Very late presentation in ST elevation myocardial infarction: predictors and long-term mortality. IJC Heart Vasc 22:156–159

    Article  Google Scholar 

  21. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, Antman EM (2007) Diabetes and mortality following acute coronary syndromes. JAMA 298:765–775

    Article  CAS  Google Scholar 

  22. Chandrasekhar J, Dangas G, Baber U, Sartori S, Qadeer A, Aquino M, Vogel B, Faggioni M, Vijay P, Claeseen BE, Goel R, Moreno P, Krishnan P, Kovacic JC, Kini A, Mehran R, Sharma S (2020) Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI. Catheter Cardiovasc Interv 96:298–308

    Article  Google Scholar 

  23. Malmberg K, Båvenholm P, Hamsten A (1994) Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. J Am Coll Cardiol 24:592–599

    Article  CAS  Google Scholar 

  24. Orellana-Barrios M, Fires J, Nugent K, Shurmur S (2019) Glycated hemoglobin, admission blood glucose delta, and associated mortality in patients with acute ST-segment elevation myocardial infarction. Proc (Bayl Univ Med Cent) 32:325–330

    Article  Google Scholar 

  25. Baydar O, Kilic A (2020) Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarction. Cardiovasc Endocrinol Metab 9:24–29

    Article  CAS  Google Scholar 

  26. Khalfallah M, Abdelmageed R, Elgendy E, Hafez YM (2020) Incidence, predictors and outcomes of stress hyperglycemia in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Diab Vasc Dis Res 17:1479164119883983

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luis Alberto Mata Marín.

Ethics declarations

Conflict of interest

All authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mata Marín, L.A., Schmucker, J., Fach, A. et al. Prevalence and clinical characteristics of prediabetes and diabetes mellitus in young patients with ST-segment elevation myocardial infarction. Clin Res Cardiol 110, 1647–1658 (2021). https://doi.org/10.1007/s00392-021-01868-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-021-01868-1

Keywords

Navigation